![Kathryn Haviland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathryn Haviland
Ordförande på
FULCRUM THERAPEUTICS, INC.
Förmögenhet: 171 943 $ per 2026-08-31
Profil
Ms. Kathryn Haviland is an Independent Director at Avalyn Pharma, Inc., an Independent Director at Bicara Therapeutics, Inc., a Chairman at Fulcrum Therapeutics, Inc., a Member at Biopharma Executive Council and a Member at Harvard Business School Health Industry Alumni Association.
She is on the Board of Directors at Avalyn Pharma, Inc. and Bicara Therapeutics, Inc. Ms. Haviland was previously employed as a President & Chief Executive Officer by Blueprint Medicines Corp., a Vice President-Rare Diseases by Idera Pharmaceuticals, Inc., a Head-Commercial Development by Sarepta Therapeutics, Inc., and an Executive Director-Commercial Development by PTC Therapeutics, Inc. She received her undergraduate degree from Wesleyan University and an MBA from Harvard Business School.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
BICARA THERAPEUTICS INC. 0,01 % | 2026-06-09 | 7 437 ( 0,01 % ) | 171 943 $ | 2026-08-31 |
| 2026-06-30 | 0 ( -.--% ) | - $ | 2026-08-31 | |
AVALYN PHARMA INC -.--% | 2026-04-30 | 0 ( -.--% ) | - $ | 2026-08-31 |
Aktiva positioner av Kathryn Haviland
| Företag | Position | Start |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Ordförande | 2022-01-10 |
| BICARA THERAPEUTICS INC. | Direktör/Styrelseledamot | 2023-09-21 |
| AVALYN PHARMA INC. | Direktör/Styrelseledamot | 2026-03-01 |
Harvard Business School Health Industry Alumni Association | Företagsledare/Principal | - |
Biopharma Executive Council
 Biopharma Executive Council Miscellaneous Commercial ServicesCommercial Services Operates as biotech and pharmaceutical executive level membership council | Företagsledare/Principal | - |
GC Therapeutics, Inc.
 GC Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops stem cells | Ordförande | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Kathryn Haviland
| Företag | Position | Slut |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Verkställande Direktör | 2026-01-01 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Företagsledare/Principal | 2015-12-01 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Kathryn Havilands utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
87
Första gradens relationer
14
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 14 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Avalyn Pharma Inc.
 Avalyn Pharma Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops inhaled therapies to treat rare respiratory & interstitial lung diseases | Health Technology |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Harvard Business School Health Industry Alumni Association | |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fulcrum Therapeutics, Inc.
 Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
Genzyme, Inc. | |
Biopharma Executive Council
Biopharma Executive Council Miscellaneous Commercial ServicesCommercial Services Operates as biotech and pharmaceutical executive level membership council | Commercial Services |
Bicara Therapeutics, Inc.
 Bicara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and sells therapeutics for tumors | Health Technology |
GC Therapeutics, Inc.
GC Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops stem cells | Commercial Services |
